EWA
KURA icon

EverSource Wealth Advisors’s Kura Oncology KURA Stock Holding History

EverSource Wealth Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.9K Sell
3,912
-98
-2% -$925 ﹤0.01% 1876
2026
Q1 		$32.6K Sell
4,010
-1,732
-30% -$14.9K ﹤0.01% 2199
2025
Q4 		$59.7K Buy
5,742
+1,888
+49% +$19.8K ﹤0.01% 1632
2025
Q3 		$34.1K Buy
3,854
+3,072
+393% +$21.9K ﹤0.01% 1979
2025
Q2 		$4.51K Buy
782
+385
+97% +$2.36K ﹤0.01% 3202
2025
Q1 		$2.62K Buy
397
+390
+5,571% +$3.04K ﹤0.01% 2805
2024
Q4 		$61 Buy
+7
New +$101 ﹤0.01% 3615
2022
Q2 		– Sell
-135
Closed -$2K – 1806
2022
Q1 		$2K Hold
135
– – ﹤0.01% 1539
2021
Q4 		$2K Buy
+135
New +$2.19K ﹤0.01% 1569

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

EverSource Wealth Advisors's KURA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Kura Oncology (KURA) stake by 2.4% in Q2 2026, selling an estimated $925 and leaving 3,912 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

EverSource Wealth Advisors first reported a position in KURA in Q4 2021 and has held it in 9 quarters since. The position peaked at $59.7K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • EverSource Wealth Advisors held 3,912 shares of Kura Oncology worth $42.9K as of Q2 2026.
  • EverSource Wealth Advisors sold 98 Kura Oncology shares in Q2 2026, an estimated $925.
  • Kura Oncology made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1876 holding.
  • EverSource Wealth Advisors first reported a position in Kura Oncology in Q4 2021 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's Kura Oncology position peaked at $59.7K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.